MS, multiple sclerosis, 4397

N. diseases: 95; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.060 Biomarker disease BEFREE Cognitive Dysfunctions and Assessments in Multiple Sclerosis. 31214113 2019
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.060 Biomarker disease BEFREE The current classification criteria of CI in MS should be considered with caution. 31766124 2019
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.060 Biomarker disease BEFREE Future research should embark on investigating interventions that will aim to enhance CR for the prevention of CI in MS. 31374461 2019
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.060 Biomarker disease BEFREE This may expand our ability to define the limits between normal and impaired cognition in patients with Multiple Sclerosis. 30200902 2018
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.060 Biomarker disease BEFREE Cognitive Deficits in Multiple Sclerosis: Recent Advances in Treatment and Neurorehabilitation. 30345468 2018
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.060 Biomarker disease BEFREE I/DMT-based BOLD activation detects CI in MS. 27613119 2017